132
Participants
Start Date
November 2, 2020
Primary Completion Date
April 29, 2025
Study Completion Date
February 4, 2026
Oral semaglutide
Oral semaglutide treatment for 52 weeks. All participants will be dose-escalated to an individual maximum tolerated dose.
Placebo (semaglutide)
Placebo treatment for 52 weeks.
Taipei Mackay Memorial Hospital, Taipei
Chang Gung Memorial Hospital Linkou-Dept of Pediatrics, Taoyuan District
PHI University Clinic for Children's Diseases-Skopje, Skopje
Liggins Institute, Grafton
Westmead Children's Hospital- The Clinical Research Centre, Westmead
Murdoch Children's Research Institute, Parkville
Monash Children's Hospital, Clayton
Universitätsklinik für Kinder und Jugendheilkunde Haus E, Salzburg
Perth Children's' Hospital, Nedlands
Hôpital d'Enfants, Rabat
University Hospital of Athens ATTIKON, Athens
"U.G.H. Attikon, Pediatric Endocrinology Outpatient Clinic", Athens
UBMD Peds-Div of Endo/Diabetes, Buffalo
UPMC Child Hosp-Pittsburgh, Pittsburgh
Chronic Care Center, Hazmiyeh
Barry J. Reiner, MD LLC, Baltimore
Virginia Commonwealth University_Richmond, Richmond
Virginia Commonwealth Univ, Richmond
Children's Healthcare Atlanta, Atlanta
Rambam MC - Department of Pediatrics A, Haifa
Nemours Chld Clnc Jacksonville, Jacksonville
University of South Florida Diabetes Center, Tampa
Vanderbilt University Medical Center, Nashville
University of Mississippi Medical Center, Jackson
University Of Louisville Research Foundation, Louisville
University General Hospital of Ioannina, Endocrinology, Ioannina
Indiana Uni School of Med-Ped, Indianapolis
City Clinical Hospital #9 (Dnipro) - Endocrinology department, Dnipro
"CNPE City Clinical Hospital #9 Dnipro City Council", Dnipro
Dr P V Rao - Diabetes Research Centre, Hyderabad
"AHEPA University General Hospital of Thessaloniki", Thessaloniki
University Malaya Medical Centre, Kuala Lumpur
University Malaya Medical Centre, Lembah Pantai
University Malaya Medical Centre, Kuala Lumpur
Kharkiv Regional Children's Clinical Hospital - Endocrinological department, Kharkiv
Hospital Putrajaya, Putrajaya
Consultorio de Endocrinología y Pediatría, Puebla City
Univ Of Texas Hlth Science Cntr, San Antonio
NE Clin Res of San Antonio, San Antonio
Texas Tech University HSC, Amarillo
Soroka MC - Pediatric Endocrinology, Beersheba
Children's Hospital Los Angeles - Endocrinology, Los Angeles
All India Institute of Medical Sciences, New Dehli
Eternal Heart Care Centre, Jaipur
Excel Endocrine Centre, Kolhāpur
Ramdev Rao Hospital, Hyderabad
Diabet Center SRL, Brasov
Endolife Specialty Hospitals, Guntur
Siberian State Medical University, Tomsk
"GFHI Omsk Region Regional Children's Clinical Hospital", Omsk
SSKM, Kolkata
Emergency County Hospital Constanta, Constanța
Fakultní Nemocnice Ostrava, Ostrava-Poruba
University Hospital of Athens ATTIKON, Haidari-Athens
Henry Dunant Hospital Center,2nd Internal Medicine Clinic, Athens
General Hospital of Lamia, Lamia
Univ Gen Hospital Larisa, Endocrinology & Metabolic Disease, Larissa
Jothydev's Diabetes & Research Center, Thriruvananthapuram
Jeroen Bosch Ziekenhuis, 's-Hertogenbosch
De Kinderkliniek, Almere Stad
Hospital Da Luz S.A., Lisbon
Centro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia
"Spitalul Clinic de Urgenta pentru Copii M.S.Curie", Bucharest
"Verum clinic LLC", Kyiv
Birmingham Children's Hospital, Birmingham
Lead Sponsor
Novo Nordisk A/S
INDUSTRY